                         SEQUENCE LISTING

<110>  AstraZeneca AB
       Yang, Wei
       Shi, Yi-Qun
       Dodd, John H.
 
<120>  Melanocortin Receptor-Specific Peptides

<130>  1006-123

<150>  61/184,932
<151>  2009-06-08

<160>  122   

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic peptide lactam bond

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  1

Xaa Asp His Xaa Arg Trp Lys 
1               5           


<210>  2
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclic peptide lactam bond

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe

<400>  2

Xaa Asp His Xaa Arg Trp Lys 
1               5           


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin receptor binding core sequence derived 
       from alpha-MSH

<400>  3

His Phe Arg Trp 
1               


<210>  4
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Human alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  AMIDATION

<400>  4

Ser Tyr Ser Met Glu His Phe Arg Trp Gly Lys Pro Val 
1               5                   10              


<210>  5
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding sequence derived from human 
       alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (4)..(4)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  AMIDATION

<400>  5

Ser Tyr Ser Xaa Glu His Xaa Arg Trp Gly Lys Pro Val 
1               5                   10              


<210>  6
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  6

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  7
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  7

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  8
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  8

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  9
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2,4-diCl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  9

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  10
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,4-diCl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  10

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  11
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  11

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  12
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  12

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  13
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Tyr

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  13

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  14
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  14

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  15
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  15

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  16
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  16

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  17
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  17

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  18
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-CF3)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  18

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  19
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-CF3)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  19

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  20
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-Me)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  20

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  21
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-OMe)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  21

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  22
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,5-diF)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  22

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  23
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Me)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  23

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  24
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Me)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  24

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  25
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CF3)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  25

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  26
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2,4-diMe)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  26

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  27
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-NO2)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  27

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  28
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-NO2)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  28

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  29
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-NO2)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  29

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  30
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,4-diOMe)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  30

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  31
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,4-diF)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  31

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  32
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,4,5-triF)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  32

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  33
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-NH2)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  33

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  34
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-Ph)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  34

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  35
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-tBu)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  35

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  36
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  36

Arg Glu Ser Xaa Arg Trp Xaa 
1               5           


<210>  37
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  37

Arg Glu Thr Xaa Arg Trp Xaa 
1               5           


<210>  38
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Hyp

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  38

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  39
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  39

Arg Glu Gln Xaa Arg Trp Xaa 
1               5           


<210>  40
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  40

Arg Glu Ser Xaa Arg Trp Xaa 
1               5           


<210>  41
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  41

Arg Glu Thr Xaa Arg Trp Xaa 
1               5           


<210>  42
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Hyp

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  42

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  43
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  43

Arg Glu Gln Xaa Arg Trp Xaa 
1               5           


<210>  44
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  44

Arg Glu Pro Xaa Arg Trp Xaa 
1               5           


<210>  45
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Hyp

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  45

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  46
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  46

Arg Glu Ala Xaa Arg Trp Xaa 
1               5           


<210>  47
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  47

Arg Glu Val Xaa Arg Trp Xaa 
1               5           


<210>  48
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  48

Arg Glu Asn Xaa Arg Trp Xaa 
1               5           


<210>  49
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  49

Arg Glu Thr Xaa Arg Trp Xaa 
1               5           


<210>  50
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  50

Arg Glu Ser Xaa Arg Trp Xaa 
1               5           


<210>  51
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  51

Arg Glu Gln Xaa Arg Trp Xaa 
1               5           


<210>  52
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Ser(Bzl)

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  52

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  53
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(8)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Phe(3-C(=O)-NH2)

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-Phe

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  AMIDATION

<400>  53

Arg Glu Xaa Xaa Xaa Arg Trp Xaa 
1               5               


<210>  54
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<400>  54

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  55
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Arg

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  55

Xaa Xaa His Xaa Arg Trp Glu 
1               5           


<210>  56
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Arg

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  56

Xaa Xaa His Xaa Arg Trp Glu 
1               5           


<210>  57
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Arg

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  57

Xaa Xaa His Xaa Arg Trp Glu 
1               5           


<210>  58
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Arg

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  58

Xaa Xaa His Xaa Arg Trp Glu 
1               5           


<210>  59
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Arg

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,4-diF)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  59

Xaa Xaa His Xaa Arg Trp Glu 
1               5           


<210>  60
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<400>  60

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  61
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab(Acetyl)

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  61

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  62
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Arg

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  62

Xaa Xaa His Xaa Arg Trp Glu 
1               5           


<210>  63
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  63

Arg Glu Ser Xaa Arg Trp Xaa 
1               5           


<210>  64
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  64

Arg Glu Gln Xaa Arg Trp Xaa 
1               5           


<210>  65
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Hyp

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  65

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  66
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dap

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  66

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  67
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dap

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  67

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  68
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Thr(Bzl)

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  68

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  69
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Hyp

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  69

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  70
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  70

Arg Glu Ser Xaa Arg Trp Xaa 
1               5           


<210>  71
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  71

Arg Glu Pro Xaa Arg Trp Xaa 
1               5           


<210>  72
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  72

Arg Glu Pro Xaa Arg Trp Xaa 
1               5           


<210>  73
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Met(O2)

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  73

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  74
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  74

Arg Glu Asn Xaa Arg Trp Xaa 
1               5           


<210>  75
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  75

Arg Xaa Asn Xaa Arg Trp Glu 
1               5           


<210>  76
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  76

Arg Xaa Asn Xaa Arg Trp Glu 
1               5           


<210>  77
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Me)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  77

Arg Xaa Asn Xaa Arg Trp Glu 
1               5           


<210>  78
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Me)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  78

Arg Glu Asn Xaa Arg Trp Xaa 
1               5           


<210>  79
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Me)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  79

Arg Xaa Asn Xaa Arg Trp Glu 
1               5           


<210>  80
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,4-diF)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  80

Arg Xaa Asn Xaa Arg Trp Glu 
1               5           


<210>  81
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,5-diF)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  81

Arg Glu Asn Xaa Arg Trp Xaa 
1               5           


<210>  82
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,5-diF)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  82

Arg Xaa Asn Xaa Arg Trp Glu 
1               5           


<210>  83
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,4-diF)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  83

Xaa Asp Gln Xaa Arg Trp Lys 
1               5           


<210>  84
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  84

Xaa Asp Gln Xaa Arg Trp Lys 
1               5           


<210>  85
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  85

Xaa Asp Gln Xaa Arg Trp Lys 
1               5           


<210>  86
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  86

Xaa Asp Gln Xaa Arg Trp Lys 
1               5           


<210>  87
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  87

Xaa Asp Gln Xaa Arg Trp Lys 
1               5           


<210>  88
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Arg

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  88

Xaa Asp Gln Xaa Arg Trp Lys 
1               5           


<210>  89
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  89

Arg Glu Asn Xaa Arg Trp Xaa 
1               5           


<210>  90
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<400>  90

Arg Glu Asn Xaa Arg Trp Xaa 
1               5           


<210>  91
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<400>  91

Arg Glu Gln Xaa Arg Trp Xaa 
1               5           


<210>  92
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Dab

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-OMe)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  92

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  93
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  93

Arg Glu Pro Xaa Arg Trp Xaa 
1               5           


<210>  94
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  94

Arg Asp Asn Xaa Arg Trp Lys 
1               5           


<210>  95
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  95

Arg Asp Gln Xaa Arg Trp Lys 
1               5           


<210>  96
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  96

Arg Xaa Asn Xaa Arg Trp Glu 
1               5           


<210>  97
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  97

Arg Glu Gln Xaa Arg Trp Xaa 
1               5           


<210>  98
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  98

Arg Lys Gln Xaa Arg Trp Asp 
1               5           


<210>  99
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  99

Arg Xaa Gln Xaa Arg Trp Glu 
1               5           


<210>  100
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,4,5-triF)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  100

Arg Glu Asn Xaa Arg Trp Xaa 
1               5           


<210>  101
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,4,5-triF)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  101

Arg Xaa Asn Xaa Arg Trp Glu 
1               5           


<210>  102
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,4,5-triF)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  102

Arg Glu Gln Xaa Arg Trp Xaa 
1               5           


<210>  103
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3,4,5-triF)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  103

Arg Xaa Gln Xaa Arg Trp Glu 
1               5           


<210>  104
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  104

Arg Glu Arg Xaa Arg Trp Xaa 
1               5           


<210>  105
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  105

Arg Glu Lys Xaa Arg Trp Xaa 
1               5           


<210>  106
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(3-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  106

Arg Glu Xaa Xaa Arg Trp Xaa 
1               5           


<210>  107
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<400>  107

Arg Glu Pro Xaa Arg Trp Xaa 
1               5           


<210>  108
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  108

Arg Asp Pro Xaa Arg Trp Lys 
1               5           


<210>  109
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  109

Arg Asp Pro Xaa Arg Trp Lys 
1               5           


<210>  110
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-F)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  110

Arg Xaa Pro Xaa Arg Trp Glu 
1               5           


<210>  111
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  111

Arg Glu Asp Xaa Arg Trp Xaa 
1               5           


<210>  112
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<400>  112

Arg Glu Asp Xaa Arg Trp Xaa 
1               5           


<210>  113
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  113

Arg Glu Glu Xaa Arg Trp Xaa 
1               5           


<210>  114
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(4-CN)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<400>  114

Arg Glu Glu Xaa Arg Trp Xaa 
1               5           


<210>  115
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Me)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  115

Arg Glu Gln Xaa Arg Trp Xaa 
1               5           


<210>  116
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Me)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  116

Arg Xaa Gln Xaa Arg Trp Glu 
1               5           


<210>  117
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  117

Arg Xaa Gln Xaa Arg Trp Glu 
1               5           


<210>  118
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-Cl)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  118

Arg Xaa Asn Xaa Arg Trp Glu 
1               5           


<210>  119
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-CF3)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  119

Arg Glu Gln Xaa Arg Trp Xaa 
1               5           


<210>  120
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-CF3)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  120

Arg Xaa Gln Xaa Arg Trp Glu 
1               5           


<210>  121
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-CF3)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  Orn

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  121

Arg Glu Asn Xaa Arg Trp Xaa 
1               5           


<210>  122
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic melanocortin binding peptide derived from human 
       NDP-alpha-MSH


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYLATION

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Orn

<220>
<221>  MISC_FEATURE
<222>  (2)..(7)
<223>  cyclized

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-Phe(2-CF3)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION

<400>  122

Arg Xaa Asn Xaa Arg Trp Glu 
1               5           


